ReP USP - Resultado da busca

Artigo de periodico
West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery (2025)
Kocabiyik, Deren Zehra ; Álvarez, Lizdany Flórez ; Durigon, Edison Luiz ; Wrenger, Carsten
Source: Frontiers in Cellular and Infection Microbiology. Unidade: ICB
Subjects: MICROBIOLOGIA, PARASITOLOGIA, VACINAS VIRAIS, ARBOVÍRUS, INFECÇÕES POR ARBOVIRUS, ANTIVIRAIS, DOENÇAS TRANSMISSÍVEIS, PROTEÍNAS, FLAVIVIRUS, REPLICAÇÃO VIRAL, CULEX, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOCABIYIK, Deren Zehra et al. West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery. Frontiers in Cellular and Infection Microbiology, v. 15, p. 9 , 2025Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2025.1568031. Acesso em: 22 nov. 2025.
APA
Kocabiyik, D. Z., Álvarez, L. F., Durigon, E. L., & Wrenger, C. (2025). West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery. Frontiers in Cellular and Infection Microbiology, 15, 9 . doi:10.3389/fcimb.2025.1568031
NLM
Kocabiyik DZ, Álvarez LF, Durigon EL, Wrenger C. West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery [Internet]. Frontiers in Cellular and Infection Microbiology. 2025 ; 15 9 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fcimb.2025.1568031
Vancouver
Kocabiyik DZ, Álvarez LF, Durigon EL, Wrenger C. West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery [Internet]. Frontiers in Cellular and Infection Microbiology. 2025 ; 15 9 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fcimb.2025.1568031
Artigo de periodico
Seroprevalence and placental transfer of zika and dengue virus antibodies in postpartum women in Southeast Brazil (2025)
Machado, Rafael Rahal Guaragna ; Peres, Marcella Sanches ; Pereira, Samuel Santos ; Mello, Ralyria Melyria ; Araújo, Danielle Bastos ; Pereira, Camila Soares ; Pastorino, Boris; Oliveira, Danielle Bruna Leal de ; Faleiros, Michele da Silva Jordan; Francisco, Rossana Pulcineli Vieira ; Yoshizaki, Carlos Tadashi; Ibidi, Silvia Maria ; Xavier de Lamballerie ; Ferreira, Luís Carlos de Souza ; Durigon, Edison Luiz
Source: Journal of Medical Virology. Unidades: FM, HU, ICB
Subjects: MICROBIOLOGIA, ZIKA VÍRUS, DENGUE, ANTICORPOS, PLACENTA, GRAVIDEZ, FATORES DE RISCO, ESTUDOS SOROEPIDEMIOLÓGICOS, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Rafael Rahal Guaragna et al. Seroprevalence and placental transfer of zika and dengue virus antibodies in postpartum women in Southeast Brazil. Journal of Medical Virology, v. 97, n. 5, p. 15 , 2025Tradução . . Disponível em: https://doi.org/10.1002/jmv.70384. Acesso em: 22 nov. 2025.
APA
Machado, R. R. G., Peres, M. S., Pereira, S. S., Mello, R. M., Araújo, D. B., Pereira, C. S., et al. (2025). Seroprevalence and placental transfer of zika and dengue virus antibodies in postpartum women in Southeast Brazil. Journal of Medical Virology, 97( 5), 15 . doi:10.1002/jmv.70384
NLM
Machado RRG, Peres MS, Pereira SS, Mello RM, Araújo DB, Pereira CS, Pastorino B, Oliveira DBL de, Faleiros M da SJ, Francisco RPV, Yoshizaki CT, Ibidi SM, Xavier de Lamballerie, Ferreira LC de S, Durigon EL. Seroprevalence and placental transfer of zika and dengue virus antibodies in postpartum women in Southeast Brazil [Internet]. Journal of Medical Virology. 2025 ; 97( 5): 15 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1002/jmv.70384
Vancouver
Machado RRG, Peres MS, Pereira SS, Mello RM, Araújo DB, Pereira CS, Pastorino B, Oliveira DBL de, Faleiros M da SJ, Francisco RPV, Yoshizaki CT, Ibidi SM, Xavier de Lamballerie, Ferreira LC de S, Durigon EL. Seroprevalence and placental transfer of zika and dengue virus antibodies in postpartum women in Southeast Brazil [Internet]. Journal of Medical Virology. 2025 ; 97( 5): 15 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1002/jmv.70384
Artigo de periodico
P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity (2025)
Gomes, Vinicius de Morais ; Santos, Deivid Martins ; Macedo-da-Silva, Janaina ; Lázari, Lucas Cardoso ; Machado, Rafael Rahal Guaragna ; Santos, Ancély Ferreira dos ; Araujo, Danielle Bastos ; Coutinho, João Victor Paccini ; Arini, Gabriel Santos ; Souza, Edmarcia Elisa de ; Marques, Rodolfo Ferreira ; Boscardin, Silvia Beatriz ; Wrenger, Carsten ; Marinho, Claudio Romero Farias ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Labriola, Leticia ; Rosa-Fernandes, Livia ; Palmisano, Giuseppe
Source: Journal of Proteomics. Unidades: ICB, IQ
Subjects: MICROBIOLOGIA, PARASITOLOGIA, VARIAÇÃO GENÉTICA, PROTEÔMICA, COVID-19, INFECÇÕES POR CORONAVIRUS, RETÍCULO ENDOPLASMÁTICO, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Vinicius de Morais et al. P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity. Journal of Proteomics, v. 315, p. 17 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.jprot.2025.105397. Acesso em: 22 nov. 2025.
APA
Gomes, V. de M., Santos, D. M., Macedo-da-Silva, J., Lázari, L. C., Machado, R. R. G., Santos, A. F. dos, et al. (2025). P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity. Journal of Proteomics, 315, 17 . doi:10.1016/j.jprot.2025.105397
NLM
Gomes V de M, Santos DM, Macedo-da-Silva J, Lázari LC, Machado RRG, Santos AF dos, Araujo DB, Coutinho JVP, Arini GS, Souza EE de, Marques RF, Boscardin SB, Wrenger C, Marinho CRF, Oliveira DBL de, Durigon EL, Labriola L, Rosa-Fernandes L, Palmisano G. P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity [Internet]. Journal of Proteomics. 2025 ; 315 17 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.jprot.2025.105397
Vancouver
Gomes V de M, Santos DM, Macedo-da-Silva J, Lázari LC, Machado RRG, Santos AF dos, Araujo DB, Coutinho JVP, Arini GS, Souza EE de, Marques RF, Boscardin SB, Wrenger C, Marinho CRF, Oliveira DBL de, Durigon EL, Labriola L, Rosa-Fernandes L, Palmisano G. P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity [Internet]. Journal of Proteomics. 2025 ; 315 17 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.jprot.2025.105397
Artigo de periodico
Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants (2025)
Silva, Mariângela de Oliveira ; Daher, Isabela Pazotti ; Ibrahim, Catarina Harumi Oda ; Souza, Edmarcia Elisa de ; Postol, Edilberto; Alencar, Raquel Elaine de; Silva, Guilherme Antônio de Souza ; Marques, Rodolfo Ferreira ; Adami, Flávia Lopes ; Schuch, Viviane ; Yamoto, Marcio Massao; Almeida, Bianca da Silva ; Koike, Gabriela ; Azevedo, Isabela Resende ; Castro-Amarante, Maria Fernanda ; Rosa, Daniela Santoro ; Durigon, Edison Luiz ; Wrenger, Carsten ; Cunha Neto, Edecio ; Kalil Filho, Jorge Elias ; Boscardin, Silvia Beatriz
Source: Virology. Unidades: ICB, FM
Subjects: MICROBIOLOGIA, PARASITOLOGIA, HIBRIDOMAS, ANTICORPOS MONOCLONAIS, COVID-19, VARIAÇÃO GENÉTICA, CAMUNDONGOS, CORONAVIRUS, GLICOPROTEÍNAS, REAÇÃO CRUZADA, IMUNOFLUORESCÊNCIA EM ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants. Virology, v. 611, p. 10 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.virol.2025.110629. Acesso em: 22 nov. 2025.
APA
Silva, M. de O., Daher, I. P., Ibrahim, C. H. O., Souza, E. E. de, Postol, E., Alencar, R. E. de, et al. (2025). Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants. Virology, 611, 10 . doi:10.1016/j.virol.2025.110629
NLM
Silva M de O, Daher IP, Ibrahim CHO, Souza EE de, Postol E, Alencar RE de, Silva GA de S, Marques RF, Adami FL, Schuch V, Yamoto MM, Almeida B da S, Koike G, Azevedo IR, Castro-Amarante MF, Rosa DS, Durigon EL, Wrenger C, Cunha Neto E, Kalil Filho JE, Boscardin SB. Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants [Internet]. Virology. 2025 ; 611 10 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.virol.2025.110629
Vancouver
Silva M de O, Daher IP, Ibrahim CHO, Souza EE de, Postol E, Alencar RE de, Silva GA de S, Marques RF, Adami FL, Schuch V, Yamoto MM, Almeida B da S, Koike G, Azevedo IR, Castro-Amarante MF, Rosa DS, Durigon EL, Wrenger C, Cunha Neto E, Kalil Filho JE, Boscardin SB. Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants [Internet]. Virology. 2025 ; 611 10 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.virol.2025.110629
Artigo de periodico
Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection (2025)
Santos, Yasmin da Silva ; Pagni, Roberta Liberato ; Gamon, Thaís Helena Martins; Azevedo, Marcela Santiago Pacheco de ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Luvizotto, Maria Cecília Rui; Ackerman, Hans Christian; Marinho, Claudio Romero Farias ; Carvalho, Leonardo José de Moura ; Epiphanio, Sabrina
Source: International Journal of Molecular Sciences. Unidades: ICB, FCF
Subjects: COVID-19, CAMUNDONGOS, ANTAGONISMO DE DROGAS, ANGIOTENSINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin da Silva et al. Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection. International Journal of Molecular Sciences, v. 26, p. 1-18 art.7663, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/ijms26167663. Acesso em: 22 nov. 2025.
APA
Santos, Y. da S., Pagni, R. L., Gamon, T. H. M., Azevedo, M. S. P. de, Darido, M. L. G., Oliveira, D. B. L. de, et al. (2025). Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection. International Journal of Molecular Sciences, 26, 1-18 art.7663. doi:10.3390/ijms26167663
NLM
Santos Y da S, Pagni RL, Gamon THM, Azevedo MSP de, Darido MLG, Oliveira DBL de, Durigon EL, Luvizotto MCR, Ackerman HC, Marinho CRF, Carvalho LJ de M, Epiphanio S. Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection [Internet]. International Journal of Molecular Sciences. 2025 ; 26 1-18 art.7663.[citado 2025 nov. 22 ] Available from: https://dx.doi.org/10.3390/ijms26167663
Vancouver
Santos Y da S, Pagni RL, Gamon THM, Azevedo MSP de, Darido MLG, Oliveira DBL de, Durigon EL, Luvizotto MCR, Ackerman HC, Marinho CRF, Carvalho LJ de M, Epiphanio S. Angiotensin converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection [Internet]. International Journal of Molecular Sciences. 2025 ; 26 1-18 art.7663.[citado 2025 nov. 22 ] Available from: https://dx.doi.org/10.3390/ijms26167663
Artigo de periodico
Plant-derived extracts and natural products with antiviral activity (2025)
Ribeiro, Giovane de Jesus Gomes ; Souza, Edmarcia Elisa de ; Liebau, Eva ; Palmisano, Giuseppe ; Durigon, Edison Luiz ; Wrenger, Carsten
Source: Frontiers in Virology. Unidade: ICB
Subjects: MICROBIOLOGIA, PARASITOLOGIA, PLANTAS MEDICINAIS, METABÓLITOS SECUNDÁRIOS, EXTRATOS (FORMAS FARMACÊUTICAS), PRODUTOS NATURAIS, ANTIVIRAIS, VIROSES, INFECÇÕES POR VÍRUS DE DNA, INFECÇÕES POR VÍRUS DE RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Giovane de Jesus Gomes et al. Plant-derived extracts and natural products with antiviral activity. Frontiers in Virology, v. 5, 2025Tradução . . Disponível em: https://doi.org/10.3389/fviro.2025.1632734. Acesso em: 22 nov. 2025.
APA
Ribeiro, G. de J. G., Souza, E. E. de, Liebau, E., Palmisano, G., Durigon, E. L., & Wrenger, C. (2025). Plant-derived extracts and natural products with antiviral activity. Frontiers in Virology, 5. doi:10.3389/fviro.2025.1632734
NLM
Ribeiro G de JG, Souza EE de, Liebau E, Palmisano G, Durigon EL, Wrenger C. Plant-derived extracts and natural products with antiviral activity [Internet]. Frontiers in Virology. 2025 ; 5[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fviro.2025.1632734
Vancouver
Ribeiro G de JG, Souza EE de, Liebau E, Palmisano G, Durigon EL, Wrenger C. Plant-derived extracts and natural products with antiviral activity [Internet]. Frontiers in Virology. 2025 ; 5[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fviro.2025.1632734
Artigo de periodico
Angiotensin-converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection (2025)
Santos, Yasmin da Silva ; Pagni, Roberta Liberato ; Gamon, Thaís Helena Martins ; Azevedo, Marcela Santiago Pacheco de ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Luvizotto, Maria Cecília Rui ; Ackerman, Hans Christian ; Marinho, Claudio Romero Farias ; Carvalho, Leonardo José de Moura ; Epiphanio, Sabrina
Source: International Journal of Molecular Sciences. Unidades: FCF, ICB, FM, Interunidades em Biotecnologia, FMVZ
Subjects: MICROBIOLOGIA, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin da Silva et al. Angiotensin-converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection. International Journal of Molecular Sciences, v. 26, 2025Tradução . . Disponível em: https://doi.org/10.3390/ijms26167663. Acesso em: 22 nov. 2025.
APA
Santos, Y. da S., Pagni, R. L., Gamon, T. H. M., Azevedo, M. S. P. de, Darido, M. L. G., Oliveira, D. B. L. de, et al. (2025). Angiotensin-converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection. International Journal of Molecular Sciences, 26. doi:10.3390/ijms26167663
NLM
Santos Y da S, Pagni RL, Gamon THM, Azevedo MSP de, Darido MLG, Oliveira DBL de, Durigon EL, Luvizotto MCR, Ackerman HC, Marinho CRF, Carvalho LJ de M, Epiphanio S. Angiotensin-converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection [Internet]. International Journal of Molecular Sciences. 2025 ; 26[citado 2025 nov. 22 ] Available from: https://doi.org/10.3390/ijms26167663
Vancouver
Santos Y da S, Pagni RL, Gamon THM, Azevedo MSP de, Darido MLG, Oliveira DBL de, Durigon EL, Luvizotto MCR, Ackerman HC, Marinho CRF, Carvalho LJ de M, Epiphanio S. Angiotensin-converting enzyme inhibition and/or angiotensin receptor blockade modulate cytokine profiles and improve clinical outcomes in experimental COVID-19 infection [Internet]. International Journal of Molecular Sciences. 2025 ; 26[citado 2025 nov. 22 ] Available from: https://doi.org/10.3390/ijms26167663
Artigo de periodico
Potential new avian species as carriers of diverse Circoviruses (2025)
Garcia, Yasmin Luisa Neves Lemes ; Gomes, Ana Júlia Chaves ; Guerra Neto, Guilherme ; Ando, Natasha Fujii; Sanches Rodrigues, Camila; Cesario, Richard Alegria ; Domit, Camila ; Lima, Fábio Henrique; Araujo Junior, João Pessoa ; Silva, Bruna Lindolfo da ; Spilki, Fernando Rosado ; Gamon, Thaís Helena Martins ; Assis, Isabela Barbosa de ; Oliveira, Danielle Bruna Leal de ; Costa, Vivaldo Gomes da ; Calmon, Marilia de Freitas ; Rahal, Paula ; Thomazelli, Luciano Matsumiya ; Ferreira, Helena Lage ; Durigon, Edison Luiz
Source: Pathogens. Unidades: FZEA, ICB, Interunidades em Biotecnologia
Subjects: MICROBIOLOGIA, CIRCOVIRUS, CIRCOVIRIDAE, INFECÇÕES POR VÍRUS DE DNA, REAÇÃO EM CADEIA POR POLIMERASE, FILOGENIA, AVES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Yasmin Luisa Neves Lemes et al. Potential new avian species as carriers of diverse Circoviruses. Pathogens, v. 14, n. 6, p. 12 , 2025Tradução . . Disponível em: https://doi.org/10.3390/pathogens14060540. Acesso em: 22 nov. 2025.
APA
Garcia, Y. L. N. L., Gomes, A. J. C., Guerra Neto, G., Ando, N. F., Sanches Rodrigues, C., Cesario, R. A., et al. (2025). Potential new avian species as carriers of diverse Circoviruses. Pathogens, 14( 6), 12 . doi:10.3390/pathogens14060540
NLM
Garcia YLNL, Gomes AJC, Guerra Neto G, Ando NF, Sanches Rodrigues C, Cesario RA, Domit C, Lima FH, Araujo Junior JP, Silva BL da, Spilki FR, Gamon THM, Assis IB de, Oliveira DBL de, Costa VG da, Calmon M de F, Rahal P, Thomazelli LM, Ferreira HL, Durigon EL. Potential new avian species as carriers of diverse Circoviruses [Internet]. Pathogens. 2025 ; 14( 6): 12 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.3390/pathogens14060540
Vancouver
Garcia YLNL, Gomes AJC, Guerra Neto G, Ando NF, Sanches Rodrigues C, Cesario RA, Domit C, Lima FH, Araujo Junior JP, Silva BL da, Spilki FR, Gamon THM, Assis IB de, Oliveira DBL de, Costa VG da, Calmon M de F, Rahal P, Thomazelli LM, Ferreira HL, Durigon EL. Potential new avian species as carriers of diverse Circoviruses [Internet]. Pathogens. 2025 ; 14( 6): 12 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.3390/pathogens14060540
Artigo de periodico
Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses (2025)
Ho, Paulo Lee ; Medina-Armenteros, Yordanka ; Dati, Lívia Mendonça Munhoz ; Cajado-Carvalho, Daniela ; Silva, Christian Savio ; Campos, Pollyanna Fernandes ; Abreu, Patrícia Antonia Estima ; Castro, Júlia Tavares de ; Tonolli, Paulo Newton ; Fujimori, Mahyumi ; Rosa, Rhubia Silveira Martins ; Palameta, Soledad ; Miller, Michael Edward ; Sakiara, Vitor Anselmo ; Valadares, Fernanda de Lima ; Lauretti-Ferreira, Fabiana ; Holanda, Bianca Pereira Carvalho ; Macedo, Douglas Gonçalves de; Comone, Priscila; Fogaça, Natully de Souza Suffert; Bimbo, Alexandre; Moraes, Felipe Catanzaro De; Andrade, Stephane Tereza Queiroz de; Arns, Clarice Weis ; Kallas, Esper Georges ; Akamatsu, Milena Apetito ; Oliveira, Ricardo das Neves ; Ferreira, Helena Lage ; Durigon, Edison Luiz
Source: Vaccines. Unidades: FZEA, ICB
Subjects: MICROBIOLOGIA, MODELOS ANIMAIS DE DOENÇAS, INFLUENZA, IMUNOGENICIDADE DA VACINA, VACINAS VIRAIS, ADJUVANTES IMUNOLÓGICOS, HIDROCARBONETOS, ANTÍGENOS DE VÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HO, Paulo Lee et al. Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses. Vaccines, v. 13, n. 6, p. 21 , 2025Tradução . . Disponível em: https://doi.org/10.3390/vaccines13060620. Acesso em: 22 nov. 2025.
APA
Ho, P. L., Medina-Armenteros, Y., Dati, L. M. M., Cajado-Carvalho, D., Silva, C. S., Campos, P. F., et al. (2025). Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses. Vaccines, 13( 6), 21 . doi:10.3390/vaccines13060620
NLM
Ho PL, Medina-Armenteros Y, Dati LMM, Cajado-Carvalho D, Silva CS, Campos PF, Abreu PAE, Castro JT de, Tonolli PN, Fujimori M, Rosa RSM, Palameta S, Miller ME, Sakiara VA, Valadares F de L, Lauretti-Ferreira F, Holanda BPC, Macedo DG de, Comone P, Fogaça N de SS, Bimbo A, Moraes FCD, Andrade STQ de, Arns CW, Kallas EG, Akamatsu MA, Oliveira R das N, Ferreira HL, Durigon EL. Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses [Internet]. Vaccines. 2025 ; 13( 6): 21 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.3390/vaccines13060620
Vancouver
Ho PL, Medina-Armenteros Y, Dati LMM, Cajado-Carvalho D, Silva CS, Campos PF, Abreu PAE, Castro JT de, Tonolli PN, Fujimori M, Rosa RSM, Palameta S, Miller ME, Sakiara VA, Valadares F de L, Lauretti-Ferreira F, Holanda BPC, Macedo DG de, Comone P, Fogaça N de SS, Bimbo A, Moraes FCD, Andrade STQ de, Arns CW, Kallas EG, Akamatsu MA, Oliveira R das N, Ferreira HL, Durigon EL. Production and immune response against pandemic influenza candidate vaccines as preparedness against the circulating H5N1 influenza viruses [Internet]. Vaccines. 2025 ; 13( 6): 21 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.3390/vaccines13060620
Artigo de periodico
Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine (2025)
Nunes, João Pedro da Silva ; Silva, Mariângela de Oliveira ; Apostolico, Juliana de Souza ; Daher, Isabela Pazotti ; Marques, Rodolfo Ferreira ; Yamamoto, Marcio Massao ; Carvalho, Alexia Adrianne Venceslau Brito ; Amarante, Maria Fernanda de Castro ; Durigon, Edison Luiz ; Wrenger, Carsten ; Janini, Luiz Mário Ramos ; Souza, Edmarcia Elisa de ; Santos, Robert Andreata ; Maricato, Juliana Terzi ; Cunha Neto, Edecio ; Kalil, Jorge ; Boscardin, Silvia Beatriz ; Rosa, Daniela Santoro
Source: Frontiers in Immunology. Unidades: ICB, FM
Subjects: MICROBIOLOGIA, PARASITOLOGIA, LINFÓCITOS T, CORONAVIRUS, GLICOPROTEÍNAS, ANTICORPOS, COVID-19, VACINAS VIRAIS, ADJUVANTES IMUNOLÓGICOS, PROTEÍNAS RECOMBINANTES, IMUNOLOGIA CELULAR, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, João Pedro da Silva et al. Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine. Frontiers in Immunology, v. 16, 2025Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2025.1610422. Acesso em: 22 nov. 2025.
APA
Nunes, J. P. da S., Silva, M. de O., Apostolico, J. de S., Daher, I. P., Marques, R. F., Yamamoto, M. M., et al. (2025). Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine. Frontiers in Immunology, 16. doi:10.3389/fimmu.2025.1610422
NLM
Nunes JP da S, Silva M de O, Apostolico J de S, Daher IP, Marques RF, Yamamoto MM, Carvalho AAVB, Amarante MF de C, Durigon EL, Wrenger C, Janini LMR, Souza EE de, Santos RA, Maricato JT, Cunha Neto E, Kalil J, Boscardin SB, Rosa DS. Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine [Internet]. Frontiers in Immunology. 2025 ; 16[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fimmu.2025.1610422
Vancouver
Nunes JP da S, Silva M de O, Apostolico J de S, Daher IP, Marques RF, Yamamoto MM, Carvalho AAVB, Amarante MF de C, Durigon EL, Wrenger C, Janini LMR, Souza EE de, Santos RA, Maricato JT, Cunha Neto E, Kalil J, Boscardin SB, Rosa DS. Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine [Internet]. Frontiers in Immunology. 2025 ; 16[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fimmu.2025.1610422
Artigo de periodico
Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections (2025)
Santos, Ingrid Nayara Marcelino ; Alberto-Lei, Felipe ; Santos, Fernanda Fernandes ; Balera, Mariana Felix Cerqueira ; Kurihara, Mariana Neri ; Cunha, Carolina Coelho; Seriacopi, Lais Sales ; Durigon, Thomas Stravinskas ; Reis, Fernando Baldy dos ; Eisen, Ana Karolina Antunes ; Caleiro, Giovana Santos ; Klautau, Giselle Burlamaqui ; Salles, Mauro José ; Araujo, Jansen de ; Durigon, Edison Luiz
Source: Scientific Reports. Unidade: ICB
Subjects: MICROBIOLOGIA, GENÉTICA BACTERIANA, STAPHYLOCOCCUS, INFECÇÕES ESTAFILOCÓCICAS, ANTIBIÓTICOS, BIOFILMES, GENOMAS, TESTES DE SENSIBILIDADE MICROBIANA, FILOGENIA, DOENÇAS MUSCULOSQUELÉTICAS, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Ingrid Nayara Marcelino et al. Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections. Scientific Reports, v. 15, n. 1, p. 13 , 2025Tradução . . Disponível em: https://doi.org/10.1038/s41598-025-09061-4. Acesso em: 22 nov. 2025.
APA
Santos, I. N. M., Alberto-Lei, F., Santos, F. F., Balera, M. F. C., Kurihara, M. N., Cunha, C. C., et al. (2025). Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections. Scientific Reports, 15( 1), 13 . doi:10.1038/s41598-025-09061-4
NLM
Santos INM, Alberto-Lei F, Santos FF, Balera MFC, Kurihara MN, Cunha CC, Seriacopi LS, Durigon TS, Reis FB dos, Eisen AKA, Caleiro GS, Klautau GB, Salles MJ, Araujo J de, Durigon EL. Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections [Internet]. Scientific Reports. 2025 ; 15( 1): 13 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1038/s41598-025-09061-4
Vancouver
Santos INM, Alberto-Lei F, Santos FF, Balera MFC, Kurihara MN, Cunha CC, Seriacopi LS, Durigon TS, Reis FB dos, Eisen AKA, Caleiro GS, Klautau GB, Salles MJ, Araujo J de, Durigon EL. Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections [Internet]. Scientific Reports. 2025 ; 15( 1): 13 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1038/s41598-025-09061-4
Artigo de periodico
Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? insights from a Brazilian cohort (2025)
Segabinazi, Ethiene ; Tocantins, Fernando Ribeiro ; Glaser, Talita ; Maglio, Tamires Gomes ; Oliveira, Nathalia Carrijo ; Castanha, Andrelissa Gorete ; Russo, Fabiele Baldino ; Leite, Paulo Emílio Corrêa ; Brito, Anita ; Molina, Camila Vieira ; Paludo, Gabriela Prado ; Souza, Raquel de Oliveira ; Alves, Simone Ravena Maia ; Cunha, Marielton Passos ; Ulrich, Henning ; Durigon, Edison Luiz ; Braga, Patricia Cristina Baleeiro Beltrão ; Minoprio, Paola Marcella Camargo
Source: Brain Behavior and Immunity Health. Unidades: IB, IQ, ICB, Interunidades em Biotecnologia
Subjects: NEUROLOGIA, COVID-19, ASTRÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEGABINAZI, Ethiene et al. Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? insights from a Brazilian cohort. Brain Behavior and Immunity Health, v. 49, p. 1-9 art. 101115, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.bbih.2025.101115. Acesso em: 22 nov. 2025.
APA
Segabinazi, E., Tocantins, F. R., Glaser, T., Maglio, T. G., Oliveira, N. C., Castanha, A. G., et al. (2025). Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? insights from a Brazilian cohort. Brain Behavior and Immunity Health, 49, 1-9 art. 101115. doi:10.1016/j.bbih.2025.101115
NLM
Segabinazi E, Tocantins FR, Glaser T, Maglio TG, Oliveira NC, Castanha AG, Russo FB, Leite PEC, Brito A, Molina CV, Paludo GP, Souza R de O, Alves SRM, Cunha MP, Ulrich H, Durigon EL, Braga PCBB, Minoprio PMC. Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? insights from a Brazilian cohort [Internet]. Brain Behavior and Immunity Health. 2025 ; 49 1-9 art. 101115.[citado 2025 nov. 22 ] Available from: https://dx.doi.org/10.1016/j.bbih.2025.101115
Vancouver
Segabinazi E, Tocantins FR, Glaser T, Maglio TG, Oliveira NC, Castanha AG, Russo FB, Leite PEC, Brito A, Molina CV, Paludo GP, Souza R de O, Alves SRM, Cunha MP, Ulrich H, Durigon EL, Braga PCBB, Minoprio PMC. Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? insights from a Brazilian cohort [Internet]. Brain Behavior and Immunity Health. 2025 ; 49 1-9 art. 101115.[citado 2025 nov. 22 ] Available from: https://dx.doi.org/10.1016/j.bbih.2025.101115
Artigo de periodico
Polymorphism in IFNλ can impact the immune/inflammatory response to COVID-19 vaccination in older CMV-seropositive adults (2025)
Nardy, Ariane ; Monteiro, Fernanda Rodrigues ; Silva, Brenda Rodrigues ; Amaral, Jônatas Bussador do ; Oliveira, Danielle Bruna Leal de ; Candido, Érika Donizetti de Oliveira ; Durigon, Edison Luiz ; Aguiar, Andressa Simões ; Scagion, Guilherme Pereira ; Chalup, Vanessa Nascimento ; Furtado, Guilherme Eustáquio ; Shio, Marina Tiemi ; França, Carolina Nunes ; Nali, Luiz Henrique da Silva ; Bachi, André Luis Lacerda
Source: Vaccines. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDY, Ariane et al. Polymorphism in IFNλ can impact the immune/inflammatory response to COVID-19 vaccination in older CMV-seropositive adults. Vaccines, v. 13, 2025Tradução . . Disponível em: https://doi.org/10.3390/vaccines13080785. Acesso em: 22 nov. 2025.
APA
Nardy, A., Monteiro, F. R., Silva, B. R., Amaral, J. B. do, Oliveira, D. B. L. de, Candido, É. D. de O., et al. (2025). Polymorphism in IFNλ can impact the immune/inflammatory response to COVID-19 vaccination in older CMV-seropositive adults. Vaccines, 13. doi:10.3390/vaccines13080785
NLM
Nardy A, Monteiro FR, Silva BR, Amaral JB do, Oliveira DBL de, Candido ÉD de O, Durigon EL, Aguiar AS, Scagion GP, Chalup VN, Furtado GE, Shio MT, França CN, Nali LH da S, Bachi ALL. Polymorphism in IFNλ can impact the immune/inflammatory response to COVID-19 vaccination in older CMV-seropositive adults [Internet]. Vaccines. 2025 ; 13[citado 2025 nov. 22 ] Available from: https://doi.org/10.3390/vaccines13080785
Vancouver
Nardy A, Monteiro FR, Silva BR, Amaral JB do, Oliveira DBL de, Candido ÉD de O, Durigon EL, Aguiar AS, Scagion GP, Chalup VN, Furtado GE, Shio MT, França CN, Nali LH da S, Bachi ALL. Polymorphism in IFNλ can impact the immune/inflammatory response to COVID-19 vaccination in older CMV-seropositive adults [Internet]. Vaccines. 2025 ; 13[citado 2025 nov. 22 ] Available from: https://doi.org/10.3390/vaccines13080785
Artigo de periodico
Whole genome sequencing of low pathogenicity avian influenza virus (H6N2) detected from a Brazilian teal (Amazonnetta brasiliensis) in Brazil, 2023 (2024)
Araujo, Andreina de Carvalho ; Cho, Andrew Yong ; Silva, Laura Morais Nascimento ; Port, Dagoberto ; Demoliner, Meriane ; Gularte, Juliana Schons ; Filippi, Michell ; Pereira, Vyctoria Malayhka de Abreu Goes ; Fisch, Fabiane ; Palameta, Soledad ; Branco, Joaquim Olinto ; Arns, Clarice Weis ; Lee, Sun-Hak ; Spilki, Fernando Rosado ; Lee, Dong-Hun ; Ferreira, Helena Lage ; Araújo, Jansen de ; Durigon, Edison Luiz
Source: Microbiology Resource Announcements. Unidades: FZEA, ICB, FMVZ
Subjects: MICROBIOLOGIA, SEQUENCIAMENTO GENÉTICO, GENOMAS, INFLUENZA, AVES SILVESTRES, INFECÇÕES POR ORTHOMYXOVIRIDAE, INFECÇÕES POR VÍRUS DE RNA, FILOGENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Andreina de Carvalho et al. Whole genome sequencing of low pathogenicity avian influenza virus (H6N2) detected from a Brazilian teal (Amazonnetta brasiliensis) in Brazil, 2023. Microbiology Resource Announcements, p. 5 , 2024Tradução . . Disponível em: https://doi.org/10.1128/mra.00158-24. Acesso em: 22 nov. 2025.
APA
Araujo, A. de C., Cho, A. Y., Silva, L. M. N., Port, D., Demoliner, M., Gularte, J. S., et al. (2024). Whole genome sequencing of low pathogenicity avian influenza virus (H6N2) detected from a Brazilian teal (Amazonnetta brasiliensis) in Brazil, 2023. Microbiology Resource Announcements, 5 . doi:10.1128/mra.00158-24
NLM
Araujo A de C, Cho AY, Silva LMN, Port D, Demoliner M, Gularte JS, Filippi M, Pereira VM de AG, Fisch F, Palameta S, Branco JO, Arns CW, Lee S-H, Spilki FR, Lee D-H, Ferreira HL, Araújo J de, Durigon EL. Whole genome sequencing of low pathogenicity avian influenza virus (H6N2) detected from a Brazilian teal (Amazonnetta brasiliensis) in Brazil, 2023 [Internet]. Microbiology Resource Announcements. 2024 ; 5 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1128/mra.00158-24
Vancouver
Araujo A de C, Cho AY, Silva LMN, Port D, Demoliner M, Gularte JS, Filippi M, Pereira VM de AG, Fisch F, Palameta S, Branco JO, Arns CW, Lee S-H, Spilki FR, Lee D-H, Ferreira HL, Araújo J de, Durigon EL. Whole genome sequencing of low pathogenicity avian influenza virus (H6N2) detected from a Brazilian teal (Amazonnetta brasiliensis) in Brazil, 2023 [Internet]. Microbiology Resource Announcements. 2024 ; 5 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1128/mra.00158-24
Artigo de periodico
SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern (2024)
Hojo-Souza, Nathalia Satchiko ; Castro, Júlia T. de; Rivelli, Graziella Gomes ; Azevedo, Patrick Orestes de ; Oliveira, Emiliano Castro de ; Faustino, Lídia Paula ; Salazar, Natália; Bagno, Flávia Fonseca ; Carvalho, Alex F.; Rattis, Bruna Amanda da Cruz ; Lourenço, Karine Lima ; Gomes, Isabela P.; Assis, Bruna Rodrigues Dias; Piccin, Mariela Pires Cabral ; Fonseca, Flavio Guimarães da ; Souza, Renan Pedra de ; Goulart, Gisele Assis Castro ; Santiago, Helton da Costa ; Gazzinelli, Ricardo Tostes ; Silva, João Santana da ; Durigon, Edison Luiz
Source: Vaccine. Unidades: FMRP, ICB
Subjects: MICROBIOLOGIA, CAMUNDONGOS, HAMSTERS, PROTEÍNAS RECOMBINANTES, COVID-19, VACINAS VIRAIS, IMUNOGENICIDADE DA VACINA, IMUNIDADE, ADJUVANTES IMUNOLÓGICOS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOJO-SOUZA, Nathalia Satchiko et al. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern. Vaccine, v. 42, n. 26, p. 16 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2024.126394. Acesso em: 22 nov. 2025.
APA
Hojo-Souza, N. S., Castro, J. T. de, Rivelli, G. G., Azevedo, P. O. de, Oliveira, E. C. de, Faustino, L. P., et al. (2024). SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern. Vaccine, 42( 26), 16 . doi:10.1016/j.vaccine.2024.126394
NLM
Hojo-Souza NS, Castro JT de, Rivelli GG, Azevedo PO de, Oliveira EC de, Faustino LP, Salazar N, Bagno FF, Carvalho AF, Rattis BA da C, Lourenço KL, Gomes IP, Assis BRD, Piccin MPC, Fonseca FG da, Souza RP de, Goulart GAC, Santiago H da C, Gazzinelli RT, Silva JS da, Durigon EL. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern [Internet]. Vaccine. 2024 ; 42( 26): 16 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.vaccine.2024.126394
Vancouver
Hojo-Souza NS, Castro JT de, Rivelli GG, Azevedo PO de, Oliveira EC de, Faustino LP, Salazar N, Bagno FF, Carvalho AF, Rattis BA da C, Lourenço KL, Gomes IP, Assis BRD, Piccin MPC, Fonseca FG da, Souza RP de, Goulart GAC, Santiago H da C, Gazzinelli RT, Silva JS da, Durigon EL. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern [Internet]. Vaccine. 2024 ; 42( 26): 16 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.vaccine.2024.126394
Artigo de periodico
Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial (2024)
Grillo, ViniciusTadeu Ramos da Silva ; Bertanha, Matheus ; Rodrigues, Lenize da Silva ; Lima, Marcelo Andrade de; Mellucci Filho, Pedro Luciano ; Machado, Rafael Rahal Guaragna ; Sertório, Nathália Dias ; Golim, Marjorie de Assis ; Moroz, Andrei ; Braz, Aline Márcia Marques ; Moraes, Leonardo Nazário de ; Leite, Marco Antonio; Nader, Helena Bonciani ; Campos, Gustavo Constantino de ; Cardoso, Fábio Florença ; Magro, Angelo José ; Nunes, Helga Caputo ; Grotto, Rejane Maria Tommasini ; Alvarado, Rita de Cássia ; Pardini, Maria Inês de Moura Campos ; Sobreira, Marcone Lima ; Costa, Erika Alessandra Pellison Nunes da ; Barbosa, Alexandre Naime ; Fortaleza, Carlos Magno Castelo Branco ; Guzzo, Cristiane Rodrigues ; Durigon, Edison Luiz
Source: Scientific Reports. Unidade: ICB
Subjects: MICROBIOLOGIA, ANTICOAGULANTES, COVID-19, ANTIVIRAIS, ANTI-INFLAMATÓRIOS, DOENÇAS RESPIRATÓRIAS, INFECÇÕES RESPIRATÓRIAS, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRILLO, ViniciusTadeu Ramos da Silva et al. Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial. Scientific Reports, v. 14, p. 19 , 2024Tradução . . Disponível em: https://doi.org/10.1038/s41598-024-70064-8. Acesso em: 22 nov. 2025.
APA
Grillo, V. T. R. da S., Bertanha, M., Rodrigues, L. da S., Lima, M. A. de, Mellucci Filho, P. L., Machado, R. R. G., et al. (2024). Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial. Scientific Reports, 14, 19 . doi:10.1038/s41598-024-70064-8
NLM
Grillo VTR da S, Bertanha M, Rodrigues L da S, Lima MA de, Mellucci Filho PL, Machado RRG, Sertório ND, Golim M de A, Moroz A, Braz AMM, Moraes LN de, Leite MA, Nader HB, Campos GC de, Cardoso FF, Magro AJ, Nunes HC, Grotto RMT, Alvarado R de C, Pardini MI de MC, Sobreira ML, Costa EAPN da, Barbosa AN, Fortaleza CMCB, Guzzo CR, Durigon EL. Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial [Internet]. Scientific Reports. 2024 ; 14 19 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1038/s41598-024-70064-8
Vancouver
Grillo VTR da S, Bertanha M, Rodrigues L da S, Lima MA de, Mellucci Filho PL, Machado RRG, Sertório ND, Golim M de A, Moroz A, Braz AMM, Moraes LN de, Leite MA, Nader HB, Campos GC de, Cardoso FF, Magro AJ, Nunes HC, Grotto RMT, Alvarado R de C, Pardini MI de MC, Sobreira ML, Costa EAPN da, Barbosa AN, Fortaleza CMCB, Guzzo CR, Durigon EL. Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial [Internet]. Scientific Reports. 2024 ; 14 19 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1038/s41598-024-70064-8
Artigo de periodico
Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 (2024)
Santos, Yasmin Silva ; Gamon, Thaís Helena Martins ; Azevedo, Marcela Santiago Pacheco de ; Bielavsky, Mônica ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Souza, Edmarcia Elisa de ; Luvizotto, Maria Cecília Rui ; Ackerman, Hans Christian; Carvalho, Leonardo José de Moura ; Epiphanio, Sabrina ; Wrenger, Carsten ; Durigon, Edison Luiz ; Marinho, Claudio Romero Farias
Source: Frontiers in Pharmacology. Unidades: FCF, ICB, Interunidades em Biotecnologia
Subjects: PARASITOLOGIA, MICROBIOLOGIA, COVID-19, INIBIDORES DE ENZIMAS, DOENÇAS RESPIRATÓRIAS, ANGIOTENSINA II, SISTEMA RENINA-ANGIOTENSINA, ANTIVIRAIS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin Silva et al. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, v. 15, 2024Tradução . . Disponível em: https://doi.org/10.3389/fphar.2024.1414406. Acesso em: 22 nov. 2025.
APA
Santos, Y. S., Gamon, T. H. M., Azevedo, M. S. P. de, Bielavsky, M., Darido, M. L. G., Oliveira, D. B. L. de, et al. (2024). Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, 15. doi:10.3389/fphar.2024.1414406
NLM
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJ de M, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Vancouver
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJ de M, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Artigo de periodico
Mortality in sea lions is associated with the introduction of the H5N1 clade 2.3.4.4b virus in Brazil October 2023: whole genome sequencing and phylogenetic analysis (2024)
Araujo, Andreina de Carvalho ; Cho, Andrew Yong ; Silva, Laura Morais Nascimento ; Corrêa, Thaís Camilo ; Souza, Gabriela Cristini de; Macagnan, Eduardo ; Kolesnikvoas, Cristiane K. M.; Meurer, Rafael ; Vieira, Jenyffer Vierheller ; Lemos, Giulia Gaglianone ; Barreto, André Silva ; Dick, Jeferson Luis ; Groch, Karina Rejane ; Castilho, Pedro Volkmer de ; Amgarten, Deyvid Emanuel ; Malta, Fernanda de Mello ; Miller, Michael; Dorlass, Erick Gustavo ; Palameta, Soledad ; Lee, Sun-Hak ; Arns, Clarice Weis ; Pinho, João Renato Rebello ; Lee, Dong-Hun ; Ferreira, Helena Lage ; Durigon, Edison Luiz
Source: BMC Veterinary Research. Unidades: FM, FZEA, ICB, Interunidades em Bioinformática
Subjects: MICROBIOLOGIA, ORTHOMYXOVIRIDAE, VÍRUS DE RNA, INFECÇÕES POR VÍRUS DE RNA, FILOGENIA, GENOMAS, SEQUENCIAMENTO GENÉTICO, LEÕES, MAMÍFEROS MARINHOS, VARIAÇÃO GENÉTICA, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Andreina de Carvalho et al. Mortality in sea lions is associated with the introduction of the H5N1 clade 2.3.4.4b virus in Brazil October 2023: whole genome sequencing and phylogenetic analysis. BMC Veterinary Research, v. 20, n. 1, p. 8 , 2024Tradução . . Disponível em: https://doi.org/10.1186/s12917-024-04137-1. Acesso em: 22 nov. 2025.
APA
Araujo, A. de C., Cho, A. Y., Silva, L. M. N., Corrêa, T. C., Souza, G. C. de, Macagnan, E., et al. (2024). Mortality in sea lions is associated with the introduction of the H5N1 clade 2.3.4.4b virus in Brazil October 2023: whole genome sequencing and phylogenetic analysis. BMC Veterinary Research, 20( 1), 8 . doi:10.1186/s12917-024-04137-1
NLM
Araujo A de C, Cho AY, Silva LMN, Corrêa TC, Souza GC de, Macagnan E, Kolesnikvoas CKM, Meurer R, Vieira JV, Lemos GG, Barreto AS, Dick JL, Groch KR, Castilho PV de, Amgarten DE, Malta F de M, Miller M, Dorlass EG, Palameta S, Lee S-H, Arns CW, Pinho JRR, Lee D-H, Ferreira HL, Durigon EL. Mortality in sea lions is associated with the introduction of the H5N1 clade 2.3.4.4b virus in Brazil October 2023: whole genome sequencing and phylogenetic analysis [Internet]. BMC Veterinary Research. 2024 ; 20( 1): 8 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1186/s12917-024-04137-1
Vancouver
Araujo A de C, Cho AY, Silva LMN, Corrêa TC, Souza GC de, Macagnan E, Kolesnikvoas CKM, Meurer R, Vieira JV, Lemos GG, Barreto AS, Dick JL, Groch KR, Castilho PV de, Amgarten DE, Malta F de M, Miller M, Dorlass EG, Palameta S, Lee S-H, Arns CW, Pinho JRR, Lee D-H, Ferreira HL, Durigon EL. Mortality in sea lions is associated with the introduction of the H5N1 clade 2.3.4.4b virus in Brazil October 2023: whole genome sequencing and phylogenetic analysis [Internet]. BMC Veterinary Research. 2024 ; 20( 1): 8 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1186/s12917-024-04137-1
Artigo de periodico
Serotype-specific dengue virus IgG assay using EDIII-based recombinant proteins and its application in an endemic population in northeast Brazil (2024)
Pereira, Samuel Pessoa ; Machado, Rafael Rahal Guaragna ; Farias, Jéssica Pires ; Adreata-Santos, Robert ; Rodrigues-Jesus, Monica Josiane ; Fogaça, Mayanna Moreira Costa ; Souza, Milena Silva ; Martins, Eduardo Gimenes; Romano, Camila Malta ; Amorim, Jaime Henrique ; Durigon, Edison Luiz ; Ferreira, Luis Carlos de Souza
Source: Journal of Medical Virology. Unidade: ICB
Subjects: MICROBIOLOGIA, VÍRUS DA DENGUE, VÍRUS DE RNA, FLAVIVIRUS, ZIKA VÍRUS, IMUNOGLOBULINAS, PROTEÍNAS RECOMBINANTES, ANTÍGENOS DE VÍRUS, ANTICORPOS, DENGUE, INFECÇÕES POR ARBOVIRUS, CAMUNDONGOS, ELISA EM ANIMAL, TESTES SOROLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Samuel Pessoa et al. Serotype-specific dengue virus IgG assay using EDIII-based recombinant proteins and its application in an endemic population in northeast Brazil. Journal of Medical Virology, v. 96, n. 12, p. , 2024Tradução . . Disponível em: https://doi.org/10.1002/jmv.70100. Acesso em: 22 nov. 2025.
APA
Pereira, S. P., Machado, R. R. G., Farias, J. P., Adreata-Santos, R., Rodrigues-Jesus, M. J., Fogaça, M. M. C., et al. (2024). Serotype-specific dengue virus IgG assay using EDIII-based recombinant proteins and its application in an endemic population in northeast Brazil. Journal of Medical Virology, 96( 12), . doi:10.1002/jmv.70100
NLM
Pereira SP, Machado RRG, Farias JP, Adreata-Santos R, Rodrigues-Jesus MJ, Fogaça MMC, Souza MS, Martins EG, Romano CM, Amorim JH, Durigon EL, Ferreira LC de S. Serotype-specific dengue virus IgG assay using EDIII-based recombinant proteins and its application in an endemic population in northeast Brazil [Internet]. Journal of Medical Virology. 2024 ; 96( 12): .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1002/jmv.70100
Vancouver
Pereira SP, Machado RRG, Farias JP, Adreata-Santos R, Rodrigues-Jesus MJ, Fogaça MMC, Souza MS, Martins EG, Romano CM, Amorim JH, Durigon EL, Ferreira LC de S. Serotype-specific dengue virus IgG assay using EDIII-based recombinant proteins and its application in an endemic population in northeast Brazil [Internet]. Journal of Medical Virology. 2024 ; 96( 12): .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1002/jmv.70100
Artigo de periodico
Anti-respiratory syncytial virus and anti-herpes simplex virus activity of chemically engineered sulfated fucans from Cystoseira indica (2024)
Jana, Subrata; Dyna, Andre Luiz ; Pal, Saikat; Mukherjee, Shuvam ; Bissochi, Isabella Maria Tomaz ; Ogatta, Sueli Fumie Yamada ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Ray, Bimalendu ; Faccin-Galhardi, Ligia Carla ; Ray, Sayani ; Durigon, Edison Luiz
Source: Carbohydrate Polymers. Unidade: ICB
Subjects: MICROBIOLOGIA, ANTIVIRAIS, SIMPLEXVÍRUS, POLISSACARÍDEOS, HERPESVIRIDAE, REPLICAÇÃO VIRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANA, Subrata et al. Anti-respiratory syncytial virus and anti-herpes simplex virus activity of chemically engineered sulfated fucans from Cystoseira indica. Carbohydrate Polymers, v. 337, p. 13 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.carbpol.2024.122157. Acesso em: 22 nov. 2025.
APA
Jana, S., Dyna, A. L., Pal, S., Mukherjee, S., Bissochi, I. M. T., Ogatta, S. F. Y., et al. (2024). Anti-respiratory syncytial virus and anti-herpes simplex virus activity of chemically engineered sulfated fucans from Cystoseira indica. Carbohydrate Polymers, 337, 13 . doi:10.1016/j.carbpol.2024.122157
NLM
Jana S, Dyna AL, Pal S, Mukherjee S, Bissochi IMT, Ogatta SFY, Darido MLG, Oliveira DBL de, Ray B, Faccin-Galhardi LC, Ray S, Durigon EL. Anti-respiratory syncytial virus and anti-herpes simplex virus activity of chemically engineered sulfated fucans from Cystoseira indica [Internet]. Carbohydrate Polymers. 2024 ; 337 13 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.carbpol.2024.122157
Vancouver
Jana S, Dyna AL, Pal S, Mukherjee S, Bissochi IMT, Ogatta SFY, Darido MLG, Oliveira DBL de, Ray B, Faccin-Galhardi LC, Ray S, Durigon EL. Anti-respiratory syncytial virus and anti-herpes simplex virus activity of chemically engineered sulfated fucans from Cystoseira indica [Internet]. Carbohydrate Polymers. 2024 ; 337 13 .[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.carbpol.2024.122157

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Source title

Publisher

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration